|
Volumn 53, Issue 6, 2000, Pages 539-
|
Malignant melanoma and hormone replacement therapy [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTROGEN;
ESTROGEN RECEPTOR;
GESTAGEN;
ORAL CONTRACEPTIVE AGENT;
AGE;
CANCER EPIDEMIOLOGY;
CANCER INCIDENCE;
CANCER RISK;
CONTROLLED STUDY;
DRUG SAFETY;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
HYPERPIGMENTATION;
LETTER;
MALE;
MELANOMA;
POSTMENOPAUSE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SEX DIFFERENCE;
UNITED KINGDOM;
|
EID: 0033845392
PISSN: 00071226
EISSN: None
Source Type: Journal
DOI: 10.1054/bjps.2000.3390 Document Type: Letter |
Times cited : (3)
|
References (16)
|